Trinity Biotech (TRIB)
(Delayed Data from NSDQ)
$3.14 USD
+0.08 (2.61%)
Updated Jul 24, 2024 03:59 PM ET
After-Market: $3.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Trinity Biotech PLC [TRIB]
Reports for Purchase
Showing records 21 - 40 ( 102 total )
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
4Q Recap - Troponin Submission a Positive; Core Business Lags
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Proposed Tax Bill to Suspend Medical Device Excise Tax
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Inline 3Q; Troponin Submission Delay Offset by Positive Data Commentary
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
Healthcare - 3Q 2015: Quarterly Medical Technology Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Weak 2Q Financials But Positive Troponin Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
Medical Technology: 2Q15 Quarterly Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Company: Trinity Biotech PLC
Industry: Medical - Products
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Healthcare -1Q 2015: Quarterly Medical Technology Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Company: Trinity Biotech PLC
Industry: Medical - Products
Healthcare: 4Q 2014: Quarterly Medical Technology Trading - Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
3Q Mixed, Troponin Trial Suspended; Lowering PT to $21
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C